Wender; Paul A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wender; Paul A..The latest application filed is for "prodrug derivatives of protein kinase c modulators".

Company Profile

4.35.42

Wender; Paul A. - Stanford CA
Wender; Paul A. - Menlo Park CA
Wender; Paul A. - Palo Alto CA US
Wender; Paul A - Menlo Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prodrug derivatives of protein kinase C modulators Grant 11,370,743 - Wender , et al. June 28, 2	2022-06-28
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery Grant 10,961,263 - McKinlay , et al. March 30, 2	2021-03-30
Prodrug Derivatives Of Protein Kinase C Modulators App 20210002203 - Wender; Paul A. ; et al.	2021-01-07
Cell-penetrating, Guanidinium-rich Oligophosphotriesters For Drug And Probe Delivery App 20200308200 - McKinlay; Colin J. ; et al.	2020-10-01
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery Grant 10,654,875 - McKinlay , et al.	2020-05-19
Cell-penetrating, Guanidinium-rich Oligophosphotriesters For Drug And Probe Delivery App 20180319825 - McKinlay; Colin J. ; et al.	2018-11-08
Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use Grant 8,816,122 - Wender , et al. August 26, 2	2014-08-26
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells Grant 8,795,734 - Dai , et al. August 5, 2	2014-08-05
Compositions And Methods For Enhancing Drug Delivery Across And Into Epithelial Tissues App 20140213532 - Rothbard; Jonathan B. ; et al.	2014-07-31
Bryostatin analogues, synthetic methods and uses Grant 8,735,609 - Wender May 27, 2	2014-05-27
Compositions and methods for enhancing drug delivery across and into ocular tissues Grant 8,729,010 - Rothbard , et al. May 20, 2	2014-05-20
Compositions and methods for transport of molecules with enhanced release properties across biological barriers Grant 8,653,238 - Wender , et al. February 18, 2	2014-02-18
Compositions and methods for enhancing drug delivery across and into epithelial tissues Grant 8,623,833 - Rothbard , et al. January 7, 2	2014-01-07
Prostratin and structural or functional analogs thereof Grant 8,536,378 - Wender , et al. September 17, 2	2013-09-17
Bryostatin analogues, synthetic methods and uses Grant 8,497,385 - Wender July 30, 2	2013-07-30
Bryostatin Analogues, Synthetic Methods and Uses App 20130123518 - Wender; Paul A.	2013-05-16
Compositions And Methods For Enhancing Drug Delivery Across And Into Ocular Tissues App 20130096069 - Rothbard; Jonathan B. ; et al.	2013-04-18
Hydrophobic Nanotubes And Nanoparticles As Transporters For The Delivery Of Drugs Into Cells App 20130034610 - DAI; Hongjie ; et al.	2013-02-07
Compositions and methods for enhancing drug delivery across and into ocular tissues Grant 8,278,264 - Rothbard , et al. October 2, 2	2012-10-02
Transporters Comprising Spaced Arginine Moieties App 20120225826 - Wender; Paul A. ; et al.	2012-09-06
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells Grant 8,246,995 - Dai , et al. August 21, 2	2012-08-21
Prostratin and Structural or Functional Analogs Thereof App 20120101283 - Wender; Paul A. ; et al.	2012-04-26
Process to produce prostratin and structural or functional analogs thereof Grant 8,067,632 - Wender , et al. November 29, 2	2011-11-29
Compositions And Methods For Enhancing Drug Delivery Across And Into Epithelial Tissues App 20110206610 - Rothbard; Jonathan B. ; et al.	2011-08-25
Prostratin Analogs, Bryostatin Analogs, Prodrugs, Synthetic Methods, And Methods Of Use App 20110014699 - Wender; Paul A. ; et al.	2011-01-20
Bryostatin Analogues, Synthetic Methods And Uses App 20100280262 - Wender; Paul A.	2010-11-04
Compositions And Methods For Transport Of Molecules With Enhanced Release Properties Across Biological Barriers App 20100255499 - Wender; Paul A ; et al.	2010-10-07
Transporters Comprising Spaced Arginine Moieties App 20100081618 - Wender; Paul A. ; et al.	2010-04-01
Bryostatin Analogues, Synthetic Methods And Uses App 20090270492 - WENDER; PAUL A.	2009-10-29
Transporters comprising spaced arginine moieties Grant 7,585,834 - Wender , et al. September 8, 2	2009-09-08
Process to Produce Prostratin and Structural or Functional Analogs Thereof App 20090187046 - Wender; Paul A. ; et al.	2009-07-23
Novel Laulimalide Analogues As Therapeutic Agents App 20090099252 - WENDER; PAUL A.	2009-04-16
Laulimalide Analogues as Therapeutic Agents App 20080280973 - Wender; Paul A.	2008-11-13
Laulimalide And Laulimalide Analogs App 20080227851 - WENDER; PAUL A.	2008-09-18
Byrostatin analogues, synthetic methods and uses App 20070270485 - Wender; Paul A. ; et al.	2007-11-22
Compositions and methods for enhancing drug delivery across and into ocular tissues App 20070213277 - Rothbard; Jonathan B. ; et al.	2007-09-13
Bryostatin analogues, synthetic methods and uses Grant 7,256,286 - Wender , et al. August 14, 2	2007-08-14
Compositions and methods for enhancing drug delivery across and into epithelial tissues App 20070173436 - Rothbard; Jonathan B. ; et al.	2007-07-26
Kinase inhibitors and associated pharmaceutical compositions and methods of use Grant 7,232,842 - Wender , et al. June 19, 2	2007-06-19
Compositions and methods for enhancing drug delivery across and into ocular tissues Grant 7,229,961 - Rothbard , et al. June 12, 2	2007-06-12
Guanidinium transport reagents and conjugates Grant 7,169,814 - Rothbard , et al. January 30, 2	2007-01-30
Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells Grant 7,151,116 - Wender , et al. December 19, 2	2006-12-19
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells App 20060275371 - Dai; Hongjie ; et al.	2006-12-07
Bi-directional synthesis of oligoguanidine transport agents App 20060264608 - Wender; Paul A. ; et al.	2006-11-23
Bi-directional synthesis of oligoguanidine transport agents Grant 7,067,698 - Wender , et al. June 27, 2	2006-06-27
Methods and compositions for enhancing transport across biological membranes App 20060111274 - Rothbard; Jonathan B. ; et al.	2006-05-25
Compositions and methods for enhancing drug delivery across and into epithelial tissues App 20040186045 - Rothbard, Jonathan B. ; et al.	2004-09-23
Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells App 20040180841 - Wender, Paul A. ; et al.	2004-09-16
Guanidinium transport reagents and conjugates App 20040161405 - Rothbard, Jonathan B. ; et al.	2004-08-19
Kinase inhibitors and associated pharmaceutical compositions and methods of use App 20040142916 - Wender, Paul A. ; et al.	2004-07-22
Compositions and methods for enhancing drug delivery across and into epithelial tissues Grant 6,759,387 - Rothbard , et al. July 6, 2	2004-07-06
Compositions and methods for treating inflammatory diseases of the skin Grant 6,730,293 - Rothbard , et al. May 4, 2	2004-05-04
Compositions and methods for enhancing drug delivery across and into epithelial tissues Grant 6,669,951 - Rothbard , et al. December 30, 2	2003-12-30
Byrostatin analogues, synthetic methods and uses App 20030220334 - Wender, Paul A. ; et al.	2003-11-27
Guanidinium transport reagents and conjugates App 20030185788 - Rothbard, Jonathan B. ; et al.	2003-10-02
Byrostatin analogues, synthetic methods and uses Grant 6,624,189 - Wender , et al. September 23, 2	2003-09-23
Method and composition for enhancing transport across biological membranes App 20030162719 - Rothbard, Jonathan B. ; et al.	2003-08-28
Compositions and methods for enhancing drug delivery across and into epithelial tissues Grant 6,593,292 - Rothbard , et al. July 15, 2	2003-07-15
Compositions and methods for enhancing drug delivery across and into epithelial tissues App 20030083256 - Rothbard, Jonathan B. ; et al.	2003-05-01
Bi-directional synthesis of oligoguanidine transport agents App 20030073807 - Wender, Paul A. ; et al.	2003-04-17
Transporters comprising spaced arginine moieties App 20030032593 - Wender, Paul A. ; et al.	2003-02-13
Compositions and methods for enhancing drug delivery across and into ocular tissues App 20030022831 - Rothbard, Jonathan B. ; et al.	2003-01-30
Method and composition for enhancing transport across biological membranes Grant 6,495,663 - Rothbard , et al. December 17, 2	2002-12-17
Byrostatin analogues, synthetic methods and uses App 20020137789 - Wender, Paul A. ; et al.	2002-09-26
Method for enhancing transport across biological membranes App 20020131965 - Rothbard, Jonathan R. ; et al.	2002-09-19
Compositions and methods for enhancing drug delivery across and into epithelial tissues App 20020127198 - Rothbard, Jonathan B. ; et al.	2002-09-12
Compositions and methods for enhancing drug delivery across biological membranes and tissues App 20020009491 - Rothbard, Jonathan B. ; et al.	2002-01-24
Method and composition for enhancing transport across biological membranes Grant 6,306,993 - Rothbard , et al. October 23, 2	2001-10-23

Company Registrations

NCAGE Code	44CY3	WENDER PAUL A.
CAGE Code	44CY3	WENDER, PAUL A.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.